TY  - GEN
AU  - Wanebo,H J
AU  - Lee,J
AU  - Burtness,B A
AU  - Ridge,J A
AU  - Ghebremichael,M
AU  - Spencer,S A
AU  - Psyrri,D
AU  - Pectasides,E
AU  - Rimm,D
AU  - Rosen,F R
AU  - Hancock,M R
AU  - Tolba,K A
AU  - Forastiere,A A
TI  - Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)
SN  - 1569-8041
PY  - 2015///0611
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Carboplatin
KW  - Cetuximab
KW  - Chemoradiotherapy
KW  - Disease-Free Survival
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - pathology
KW  - Epithelial Cells
KW  - drug effects
KW  - Female
KW  - Head and Neck Neoplasms
KW  - drug therapy
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Paclitaxel
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1093/annonc/mdu248
ER  -